SUBSTITUTED-DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Elokdah Hassan Mahmoud
公开号:US20080280893A1
公开(公告)日:2008-11-13
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
本发明提供了一种I式化合物及其在治疗与5-HT6受体相关或受其影响的中枢神经系统疾病中的应用。
SUBSTITUTED-3-SULFONYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Wyeth
公开号:EP1931640A2
公开(公告)日:2008-06-18
SUBSTITUTED-DIHYDRO[1,4]OXAZINO[2,3,4-HI]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS